Diabetes Care
Gliclazide & Metformin Hydrochloride Extended-Release Tablets
| Brand | Ixizide-M XR 60/1000 |
|---|---|
| Generic name | Gliclazide & Metformin Hydrochloride Extended-Release Tablets |
| Dosage form | Extended-release tablet |
| Composition | Gliclazide ER 60 mg + Metformin HCl ER 1000 mg |
| Pack size | 10 x 15 tablets |
| Therapeutic area | Diabetes Care |
| Prescription status | Schedule H prescription drug |
Each tablet contains (as printed on the pack):
| Ingredient | Strength |
|---|---|
| Gliclazide IP | 60 mg |
| Metformin Hydrochloride IP (in extended-release form) | 1000 mg |
| Excipients | q.s. |
Ixizide-M XR 60/1000 is an extended-release tablet that combines gliclazide, a sulfonylurea, with metformin hydrochloride, a biguanide. It is part of the IXIA Healthcare diabetes care range and is a Schedule H prescription medicine.
IXIA product literature positions the Ixizide range for glycaemic control in diabetes care. For approved indications and dosage, refer to the prescribing information supplied with the product and the advice of the treating physician.
Store below 30°C. Protect from moisture and light. Keep the medicine out of reach of children.
For availability, trade information or product literature on Ixizide-M XR 60/1000, contact our team.
For healthcare professionals
Use this medicine only under the guidance of a registered medical practitioner. Information on this page is for general reference and does not replace professional medical advice.
Diabetes Care
Gliclazide ER 60 mg + Metformin HCl ER 500 mg
Extended-release (ER)
Diabetes Care
Gliclazide ER 60 mg
Extended-release (ER)
Pain & Inflammation
Aceclofenac 100 mg + Paracetamol 325 mg
Tablet · 10 x 10 tablets
